Growth Metrics

Regenerex Pharma (RGPX) Free Cash Flow (2011 - 2025)

Regenerex Pharma (RGPX) reported Free Cash Flow of -$519355.0 for Q3 2025, down 310.21% year-over-year from $247060.6 in Q3 2024, and down 8.66% on a QoQ basis from -$477943.0 in Q2 2025.

Regenerex Pharma (RGPX) has 13 years of Free Cash Flow data on file, last reported at -$519355.0 in Q3 2025.

  • Quarterly Free Cash Flow fell 310.21% year-over-year to -$519355.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$2.4 million (down 605.0% YoY) and the FY2025 annual result came in at -$1.6 million, down 250.67% from the prior year.
  • Free Cash Flow declined to -$519355.0 in Q3 2025 per RGPX's latest filing, from -$477943.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1362.0 in Q1 2022 and bottomed at -$1.3 million in Q1 2025.
  • The 5-year median for Free Cash Flow is -$59883.5 (2024), against an average of -$179448.4.
  • The widest annual swing landed in 2022, when Free Cash Flow jumped 66.56%; it then tumbled 2030.79% in 2024.
  • Tracing RGPX's Free Cash Flow over 5 years: stood at -$20593.0 in 2021, then sank by 39.02% to -$28628.0 in 2022, then tumbled by 248.7% to -$99827.0 in 2023, then slumped by 58.99% to -$158713.0 in 2024, then plunged by 227.23% to -$519355.0 in 2025.
  • Per Business Quant, the three latest RGPX Free Cash Flow figures stand at -$519355.0 (Q3 2025), -$477943.0 (Q2 2025), and -$1.3 million (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -519,355.00
Sep 30, 2025 -519,355.00
Jun 30, 2025 -477,943.00
Jun 30, 2025 -477,943.00
Mar 31, 2025 -1.28 Mn
Mar 31, 2025 -1.28 Mn
Dec 31, 2024 -158,713.00
Dec 31, 2024 -158,713.00
Sep 30, 2024 -126,606.00
Sep 30, 2024 -126,606.00
Jun 30, 2024 -55,332.00
Jun 30, 2024 -55,332.00
Mar 31, 2024 -64,435.00
Mar 31, 2024 -64,435.00
Dec 31, 2023 -99,827.00
Dec 31, 2023 -99,827.00
Sep 30, 2023 -174,719.00
Sep 30, 2023 -174,719.00
Jun 30, 2023 -124,866.00
Jun 30, 2023 -124,866.00
Mar 31, 2023 -3,024.00
Mar 31, 2023 -3,024.00
Dec 31, 2022 -28,628.00
Dec 31, 2022 -28,628.00
Sep 30, 2022 -9,444.00
Sep 30, 2022 -9,444.00
Jun 30, 2022 -35,068.00
Jun 30, 2022 -35,068.00
Mar 31, 2022 -1,362.00
Mar 31, 2022 -1,362.00
Dec 31, 2021 -20,593.00
Dec 31, 2021 -20,593.00
Sep 30, 2021 -28,239.00
Sep 30, 2021 -28,239.00
Jun 30, 2021 -17,218.00
Jun 30, 2021 -17,218.00
Dec 31, 2020 -16,724.00
Dec 31, 2020 -16,724.00
Sep 30, 2020 -11,703.00
Sep 30, 2020 -11,703.00
Jun 30, 2020 -9,125.00
Jun 30, 2020 -9,125.00
Mar 31, 2020 -512,139.00
Mar 31, 2020 -512,139.00
Dec 31, 2019 66,209.00
Dec 31, 2019 66,209.00
Sep 30, 2019 137,045.00
Sep 30, 2019 137,045.00
Jun 30, 2019 17,706.00
Jun 30, 2019 17,706.00
Mar 31, 2019 23,536.00
Mar 31, 2019 23,536.00
Dec 31, 2018 22,399.00
Dec 31, 2018 22,399.00
Sep 30, 2018 214.00
Sep 30, 2018 214.00
Jun 30, 2018 910.00
Jun 30, 2018 910.00
Mar 31, 2018 8,291.00
Mar 31, 2018 8,291.00
Dec 31, 2017 7,601.00
Dec 31, 2017 7,601.00
Sep 30, 2017 3,127.00
Sep 30, 2017 3,127.00
Jun 30, 2017 1,103.00
Jun 30, 2017 1,103.00
Mar 31, 2017 338.00
Mar 31, 2017 338.00
Nov 30, 2014 -26,037.00
Nov 30, 2014 -26,037.00
Aug 31, 2014 -4,130.00
Aug 31, 2014 -4,130.00
May 31, 2014 -32,185.00
May 31, 2014 -32,185.00
Feb 28, 2014 -9,289.00
Feb 28, 2014 -9,289.00
Nov 30, 2013 -6,814.00
Nov 30, 2013 -6,814.00
Aug 31, 2013 -20,098.00
Aug 31, 2013 -20,098.00
May 31, 2013 -24,411.00
May 31, 2013 -24,411.00
Feb 28, 2013 -3,000.00
Feb 28, 2013 -3,000.00
Nov 30, 2012 -5,600.00
Nov 30, 2012 -5,600.00
Aug 31, 2012 -28,393.00
Aug 31, 2012 -28,393.00
May 31, 2012 -9,005.00
May 31, 2012 -9,005.00
Feb 29, 2012 -14,518.00
Feb 29, 2012 -14,518.00
Aug 31, 2011 -30,707.00
Aug 31, 2011 -30,707.00